Dr. Tadeusz Korszun, MD

NPI: 1457373896
Total Payments
$2,243
2024 Payments
$281.13
Companies
10
Transactions
39
Medicare Patients
3,909
Medicare Billing
$504,154

Payment Breakdown by Category

Food & Beverage$2,243 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,243 39 100.0%

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $634.41 11 $0 (2023)
AstraZeneca Pharmaceuticals LP $518.67 11 $0 (2024)
Vapotherm Inc $243.04 2 $0 (2018)
ABBVIE INC. $229.22 6 $0 (2024)
Genentech USA, Inc. $194.44 2 $0 (2018)
Janssen Pharmaceuticals, Inc $146.54 2 $0 (2023)
Amgen Inc. $145.87 2 $0 (2024)
Intuitive Surgical, Inc. $100.45 1 $0 (2023)
Allergan Inc. $17.23 1 $0 (2019)
Cumberland Pharmaceuticals, Inc. $13.13 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $281.13 8 Amgen Inc. ($145.87)
2023 $354.93 8 Janssen Pharmaceuticals, Inc ($146.54)
2022 $249.83 2 AstraZeneca Pharmaceuticals LP ($249.83)
2021 $124.99 1 AbbVie Inc. ($124.99)
2020 $133.47 2 PFIZER INC. ($133.47)
2019 $334.77 7 PFIZER INC. ($305.28)
2018 $340.30 5 Vapotherm Inc ($243.04)
2017 $423.58 6 AstraZeneca Pharmaceuticals LP ($151.77)

All Payment Transactions

39 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
10/29/2024 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $31.25 General
Category: Rare Disease
10/10/2024 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $27.84 General
Category: Rare Disease
10/09/2024 ABBVIE INC. DALVANCE (Drug) Food and Beverage In-kind items and services $13.08 General
Category: ANTI-INFECTIVE
09/18/2024 ABBVIE INC. AVYCAZ (Drug), TEFLARO, DALVANCE Food and Beverage In-kind items and services $21.69 General
Category: ANTI-INFECTIVE
07/01/2024 Cumberland Pharmaceuticals, Inc. CALDOLOR (Drug) Food and Beverage In-kind items and services $13.13 General
Category: ANESTHESIOLOGY PAIN MANAGEMENT
04/18/2024 ABBVIE INC. DALVANCE (Drug) Food and Beverage In-kind items and services $28.27 General
Category: ANTI-INFECTIVE
03/05/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $24.53 General
Category: Cardiology
02/27/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $121.34 General
Category: Cardiology
12/05/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $21.54 General
Category: Cardiovascular & Metabolism
11/01/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Cardiovascular & Metabolism
10/31/2023 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $22.93 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/05/2023 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $25.92 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/22/2023 Intuitive Surgical, Inc. Da Vinci Surgical System (Device) Food and Beverage In-kind items and services $100.45 General
Category: SURGERY
05/24/2023 ABBVIE INC. TEFLARO (Drug) Food and Beverage In-kind items and services $14.61 General
Category: ANTI-INFECTIVE
05/17/2023 ABBVIE INC. AVYCAZ (Drug) Food and Beverage In-kind items and services $26.58 General
Category: ANTI-INFECTIVE
01/19/2023 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $17.90 General
Category: Rare Disease
10/27/2022 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $125.24 General
Category: Rare Disease
06/27/2022 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $124.59 General
Category: Rare Disease
12/07/2021 AbbVie Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $124.99 General
Category: ANTI-INFECTIVE
02/25/2020 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $15.66 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
02/20/2020 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $117.81 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
11/11/2019 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $16.33 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/08/2019 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $17.54 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/05/2019 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $125.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
05/15/2019 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $21.41 General
Category: CARDIOVASCULAR;METABOLIC DISEASE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 13 841 865 $630,991 $102,962
2022 13 1,362 1,433 $911,824 $162,554
2021 12 1,202 1,225 $886,392 $162,446
2020 6 504 515 $479,261 $76,192
Total Patients
3,909
Total Services
4,038
Medicare Billing
$504,154
Procedure Codes
44

All Medicare Procedures & Services

44 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99285 Emergency department visit with high level of medical decision making Facility 2023 262 266 $322,126 $45,551 14.1%
99284 Emergency department visit with moderate level of medical decision making Facility 2023 151 154 $124,124 $17,522 14.1%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 59 59 $26,373 $7,056 26.8%
99235 Initial hospital care with same-day admission and discharge with moderate level of medical decision making, per day, if using time, at least 70 minutes Facility 2023 47 47 $25,474 $6,149 24.1%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 74 74 $21,534 $5,749 26.7%
99291 Critical care, first 30-74 minutes Facility 2023 26 26 $48,984 $5,400 11.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 63 63 $12,852 $4,873 37.9%
99283 Emergency department visit with low level of medical decision making Facility 2023 68 70 $31,360 $4,630 14.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 17 17 $5,100 $1,891 37.1%
99234 Initial hospital care with same-day admission and discharge with straightforward or low level of medical decision making, per day, if using time, at least 45 minutes Facility 2023 16 16 $5,440 $1,455 26.8%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 12 12 $3,624 $1,126 31.1%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2023 31 31 $3,100 $1,073 34.6%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2023 15 30 $900.00 $486.60 54.1%
99285 Emergency department visit for life threatening or functioning severity Facility 2022 356 365 $442,015 $68,320 15.5%
99284 Emergency department visit for problem of high severity Facility 2022 266 282 $227,292 $33,273 14.6%
99283 Emergency department visit for problem of moderate severity Facility 2022 263 269 $120,512 $19,960 16.6%
99219 Initial hospital observation care per day, typically 50 minutes Facility 2022 96 97 $44,232 $11,653 26.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 93 93 $18,972 $9,341 49.2%
99218 Initial hospital observation care per day, typically 30 minutes Facility 2022 63 63 $21,546 $5,596 26.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 29 30 $9,000 $3,894 43.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 28 28 $8,456 $3,321 39.3%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2022 90 90 $9,000 $3,134 34.8%
99235 Hospital observation or inpatient care admitted and discharged on the same day for moderate severity problem, typically 50 minutes Facility 2022 11 11 $6,248 $1,681 26.9%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2022 37 74 $2,220 $1,202 54.1%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 18 18 $2,214 $1,135 51.2%

About Dr. Tadeusz Korszun, MD

Dr. Tadeusz Korszun, MD is a Emergency Medicine healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457373896.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tadeusz Korszun, MD has received a total of $2,243 in payments from pharmaceutical and medical device companies, with $281.13 received in 2024. These payments were reported across 39 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,243).

As a Medicare-enrolled provider, Korszun has provided services to 3,909 Medicare beneficiaries, totaling 4,038 services with total Medicare billing of $504,154. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.

Practice Information

  • Specialty Emergency Medicine
  • Other Specialties Diagnostic Ultrasound
  • Location Manhasset, NY
  • Active Since 07/24/2006
  • Last Updated 07/29/2008
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • NPI Number 1457373896

Products in Payments

  • ELIQUIS (Drug) $634.41
  • ANDEXXA (Biological) $326.82
  • Precision Flow (Device) $243.04
  • BRILINTA (Drug) $191.85
  • DALVANCE (Drug) $183.57
  • XARELTO (Drug) $146.54
  • Repatha (Biological) $145.87
  • Da Vinci Surgical System (Device) $100.45
  • AVYCAZ (Drug) $48.27
  • TEFLARO (Drug) $14.61
  • CALDOLOR (Drug) $13.13

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in Manhasset